Core Laboratories N.V. (CLB) Income Statement
CLB 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsCLB revenue and net income
Where CLB's revenue goes
2025Each bar shows an amount and its share of revenue. CLB kept 5.6% of revenue as net income.
CLB profit margins
CLB growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +0.5% | +2.4% | +1.6% | −4.1% |
| Gross profit | +6.7% | +6.1% | −1.6% | −8.8% |
| Operating income | −13.8% | +6.7% | — | −11.0% |
| Net income | −5.5% | +15.1% | — | −12.7% |
| EPS (diluted) | −13.6% | +9.4% | −0.8% | −13.3% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
CLB quarterly EPS vs estimates
Core Laboratories beat the analyst EPS estimate in 6 of the last 8 quarters. Next report: October 28, 2026 (estimate $0.17).
CLB income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $526.5M | $523.8M | $509.8M | $489.7M | $470.3M | $487.3M | $668.2M | $700.8M | $659.8M | $594.7M |
| Cost of revenue | $432.2M | $435.5M | $415.7M | $410.8M | $386.4M | $385.1M | $495.6M | $520.1M | $499.2M | $469.5M |
| Gross profit | $94.3M | $88.4M | $94.0M | $78.9M | $83.8M | $102.1M | $172.6M | $180.8M | $160.6M | $125.2M |
| Research & development | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Sales, general & admin | $44.2M | $38.6M | $40.3M | $38.1M | $44.2M | $35.5M | $49.5M | $62.9M | $47.7M | $39.4M |
| Total operating expenses | $43.8M | $29.8M | $39.4M | $37.4M | $38.6M | $178.9M | $75.9M | $62.9M | $47.7M | $39.4M |
| Operating income | $50.5M | $58.6M | $54.6M | $41.5M | $45.3M | −$76.8M | $96.7M | $118.6M | $112.4M | $86.2M |
| Interest income | $10.6M | $12.4M | $13.4M | $11.6M | $9.2M | $14.4M | $14.7M | $13.3M | $10.7M | $11.6M |
| Interest expense | $10.6M | $12.4M | $13.4M | $11.6M | $9.2M | $14.4M | $14.7M | $13.3M | $10.7M | $11.6M |
| Income before taxes | $45.9M | $46.2M | $41.2M | $30.0M | $36.1M | −$91.2M | $82.0M | $105.3M | $101.7M | $74.6M |
| Income taxes | $15.5M | $14.0M | $4.2M | $10.3M | $15.9M | $5.9M | −$12.3M | $25.4M | $18.6M | $10.7M |
| Net income | $29.7M | $31.4M | $36.7M | $19.5M | $19.7M | −$97.6M | $102.0M | $79.5M | $83.1M | $63.9M |
| EBITDA | $71.1M | $73.5M | $70.4M | $58.7M | $63.8M | $70.5M | $124.6M | $141.7M | $134.5M | $113.1M |
| EPS (diluted) | $0.76 | $0.88 | $0.81 | $0.58 | $0.71 | $0.79 | $1.78 | $2.28 | $2.00 | $1.51 |
| Gross margin | 17.9% | 16.9% | 18.4% | 16.1% | 17.8% | 21.0% | 25.8% | 25.8% | 24.3% | 21.1% |
| Operating margin | 9.6% | 11.2% | 10.7% | 8.5% | 9.6% | −15.8% | 14.5% | 16.9% | 17.0% | 14.5% |
| Net margin | 5.6% | 6.0% | 7.2% | 4.0% | 4.2% | −20.0% | 15.3% | 11.3% | 12.6% | 10.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $124.6M | $121.8M | $138.3M | $134.5M | $130.2M | $123.6M | $129.2M | $134.4M | $130.6M | $129.6M | $128.2M | $125.3M |
| Cost of revenue | $101.4M | $102.1M | $113.2M | $108.5M | $107.4M | $103.2M | $109.9M | $110.5M | $106.7M | $108.4M | $101.5M | $100.5M |
| Gross profit | $23.2M | $19.7M | $25.1M | $26.0M | $22.8M | $20.4M | $19.4M | $23.9M | $23.9M | $21.2M | $26.7M | $24.8M |
| Sales, general & admin | $11.0M | $14.7M | $9.4M | $10.7M | $10.5M | $13.6M | $9.1M | $8.3M | $10.3M | $11.8M | $9.0M | $9.8M |
| Total operating expenses | $14.1M | $17.8M | $9.0M | $5.1M | $7.5M | $16.0M | $5.2M | $4.1M | $7.9M | $12.6M | $12.1M | $10.1M |
| Operating income | $9.2M | $1.9M | $16.1M | $20.9M | $15.3M | $4.4M | $14.2M | $19.8M | $16.0M | $8.6M | $14.6M | $14.7M |
| Interest income | — | — | $2.6M | $2.6M | $2.7M | $2.6M | $2.6M | $3.1M | — | — | — | — |
| Interest expense | $2.8M | $2.9M | $2.6M | $2.6M | $2.7M | $2.6M | $2.6M | $3.1M | $3.2M | $3.4M | $3.6M | $3.1M |
| Income before taxes | $6.3M | −$1.0M | $13.2M | $18.3M | $12.6M | $1.8M | $11.5M | $16.7M | $12.8M | $5.1M | $11.0M | $11.5M |
| Income taxes | $507,000 | −$251,000 | $8.1M | $3.8M | $1.9M | $1.7M | $4.1M | $4.7M | $3.6M | $1.7M | $8.5M | $2.3M |
| Net income | $6.0M | −$789,000 | $4.9M | $14.2M | $10.6M | −$154,000 | $7.4M | $11.7M | $9.0M | $3.2M | $2.2M | $9.3M |
| EBITDA | $13.0M | $5.7M | $19.5M | $24.5M | $19.0M | $8.1M | $17.8M | $23.5M | $19.8M | $12.4M | $18.8M | $18.6M |
| EPS (diluted) | $0.11 | $0.06 | $0.21 | $0.22 | $0.19 | $0.14 | $0.22 | $0.25 | $0.22 | $0.19 | $0.19 | $0.22 |
| Gross margin | 18.6% | 16.2% | 18.1% | 19.3% | 17.5% | 16.5% | 15.0% | 17.8% | 18.3% | 16.4% | 20.8% | 19.8% |
| Operating margin | 7.3% | 1.5% | 11.6% | 15.6% | 11.7% | 3.6% | 11.0% | 14.7% | 12.3% | 6.6% | 11.4% | 11.7% |
| Net margin | 4.8% | −0.6% | 3.6% | 10.6% | 8.2% | −0.1% | 5.7% | 8.7% | 6.9% | 2.5% | 1.7% | 7.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in CLB's financial statements (latest annual report filed March 23, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
CLB financial results
In fiscal year 2025 (ended December 31, 2025), Core Laboratories reported revenue of $526.5 million, up 0.5% from the year before. It had net income of $29.7 million (down 5.5%), a net profit margin of 5.6%. Diluted earnings per share came to $0.76. Over five years revenue grew at an average rate of 1.6% a year.
See the CLB stock overview for the latest quote and news, or the CLB chart for price history and technical indicators.
CLB income statement FAQ
What is Core Laboratories's annual revenue?
Core Laboratories reported total revenue of $526.5 million for fiscal year 2025, which ended on December 31, 2025. That was up 0.5% from $523.8 million the previous year.
Is Core Laboratories profitable?
Yes. Core Laboratories reported net income of $29.7 million in fiscal 2025, a net profit margin of 5.6%; its operating margin was 9.6%.
What is Core Laboratories's gross margin?
Core Laboratories's gross margin was 17.9% in fiscal 2025: for every $100 of revenue, Core Laboratories kept $18 after the direct cost of its products and services.
How fast is Core Laboratories growing?
Revenue grew 1.6% a year on average over the last five fiscal years, from $487.3 million to $526.5 million.
What are Core Laboratories's earnings per share?
Core Laboratories earned $0.76 per diluted share in fiscal 2025, compared with $0.88 a year earlier.
When will Core Laboratories report its next earnings?
Core Laboratories is expected to report results for the quarter ending September 30, 2026 on October 28, 2026 after the market closes.
When does Core Laboratories's fiscal year end?
Core Laboratories's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 23, 2026.